Mesothelin expression in pancreatic mucinous cysts
Document Type
Journal Article
Publication Date
1-1-2014
Journal
American Journal of Clinical Pathology
Volume
142
Issue
3
DOI
10.1309/AJCPDTTL2I5ECMFG
Keywords
Mesothelin; Mucinous cysts; Pancreas
Abstract
© American Society for Clinical Pathology. Objectives: Mesothelin (MSLN) is a differentiation antigen found to be overexpressed in intraductal papillary mucinous neoplasms (IPMNs) and is a potential treatment target in pancreatic ductal adenocarcinoma.Methods: From institutional archives, 114 cases of resected pancreatic mucinous cysts were identified, including IPMN and mucinous cystic neoplasm (MCN). Immunohistochemical analysis of MSLN was performed on representative sections.Results: MSLN was seen more frequently in neoplastic epithelial cells from IPMN (39/52; P < .0005) and MCN (9/14; P < .0001) compared with unremarkable adjacent pancreatic and bile ducts (0/57) and benign foveolar and duodenal epithelium (0/21). When present, MSLN was diffusely expressed in neoplastic epithelium and only focally expressed in adjacent ducts (8/57). No significant difference was seen (P = .26) in MLSN expression between IPMN (79%) and MCN (83%) when only presence or absence was considered.Conclusion: Our findings suggest that MLSN can be used as a marker of neoplastic transformation of epithelial cells in pancreatic mucinous cysts. The findings can help identify neoplastic mucinous epithelium.
APA Citation
Frank, R., Li, S., Ahmad, N., Sepulveda, A., & Jhala, N. (2014). Mesothelin expression in pancreatic mucinous cysts. American Journal of Clinical Pathology, 142 (3). http://dx.doi.org/10.1309/AJCPDTTL2I5ECMFG
